SAN JOSE, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the first quarter ended March 31, 2026. First Quarter and Recent Highlights Net revenue totaled $27.9 million, a decrease of 6% compared to $29.8 million in the first quarter of 2025.Recurring revenue consisting of Tablo consumables and services ...